1. Home
  2. STRA vs HRMY Comparison

STRA vs HRMY Comparison

Compare STRA & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

STRA

Strategic Education Inc.

HOLD

Current Price

$83.20

Market Cap

1.9B

Sector

Real Estate

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$38.57

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRA
HRMY
Founded
2017
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
STRA
HRMY
Price
$83.20
$38.57
Analyst Decision
Buy
Strong Buy
Analyst Count
2
9
Target Price
$96.50
$51.00
AVG Volume (30 Days)
214.0K
633.0K
Earning Date
02-26-2026
02-24-2026
Dividend Yield
2.88%
N/A
EPS Growth
N/A
50.44
EPS
4.81
3.17
Revenue
$1,256,466,000.00
$825,944,000.00
Revenue This Year
$5.99
$23.11
Revenue Next Year
$3.79
$16.15
P/E Ratio
$17.33
$12.17
Revenue Growth
3.74
21.13
52 Week Low
$72.25
$25.52
52 Week High
$104.51
$40.93

Technical Indicators

Market Signals
Indicator
STRA
HRMY
Relative Strength Index (RSI) 56.46 59.87
Support Level $80.82 $35.42
Resistance Level $85.95 $38.11
Average True Range (ATR) 2.34 1.02
MACD 0.20 -0.22
Stochastic Oscillator 64.42 74.40

Price Performance

Historical Comparison
STRA
HRMY

About STRA Strategic Education Inc.

Strategic Education Inc. is an education services company that provides access to high-quality education through campus-based and online post-secondary education offerings, as well as through programs to develop job-ready skills for high-demand markets. The company operates through wholly-owned subsidiaries Strayer University and Capella University, both accredited post-secondary institutions of higher education located in the United States, as well as Torrens University, an accredited post-secondary institution of higher education located in Australia. It provide employees with access to affordable and industry relevant training, certificate, and degree programs. The reportable segments of the company are U.S. Higher Education, Australia/New Zealand and Education Technology Services.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: